Status:
COMPLETED
Heparin-Induced Thrombocytopenia Registry
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Tanabe Pharma Corporation
Conditions:
Heparin-Induced Thrombocytopenia
Eligibility:
All Genders
Brief Summary
The purpose of the Heparin Induced Thrombocytopenia Registry is to explore the frequency of heparin-induced thrombocytopenia (HIT) at Brigham and Women's Hospital and to assess its mortality rate. Ret...
Detailed Description
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction with potentially fatal complications of venous and arterial thrombosis. HIT with thrombosis causes prolonged hospita...
Eligibility Criteria
Inclusion
- All patients hospitalized at BWH who have a PF4-Positive antibody test
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
242 Patients enrolled
Trial Details
Trial ID
NCT00456326
Start Date
October 1 2005
End Date
August 1 2007
Last Update
February 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115